language |
eng
|
Author |
Michihiro Hide
Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Hae-Sim Park
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea
Atsuyuki Igarashi
Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan
Young-Min Ye
Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea
Tae-Bum Kim
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Akiko Yagami
Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
Jooyoung Roh
Department of Dermatology, Gachon University Gil Medical Center, Incheon, Korea
Jae-Hyun Lee
Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea
Woong Youn Sang
Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea
Soo-Keol Lee
Department of Internal Medicine, Dong-A University School of Medicine, Busan, Korea
Naoko Inomata
Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
Jeong-Hee Choi
Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea
Atsushi Fukunaga
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Junyi Wang
Novartis Pharma K.K., Tokyo, Japan
Soichiro Matsushima
Novartis Pharma K.K., Tokyo, Japan
Steve Greenberg
Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
Sam Khalil
Novartis Pharma AG, Basel, Switzerland
|
Subject | Antihistamines; Chronic spontaneous urticaria; Japan; Korea; Omalizumab
|
Journal Title |
JOURNAL OF DERMATOLOGICAL SCIENCE
|
Volume | 87
|
Issue | 1
|
Start Page | 70
|
End Page | 78
|
ISSN | 0923-1811
|
ISSN(Online) | 1873-569X
|
Published Date | 2017-07
|
DOI | |
PubMed ID | |
Publisher | ELSEVIER IRELAND LTD
|
NII Type |
Journal Article
|
OAI-PMH Set |
Faculty of Medicine
|
Remark | This study was funded by Novartis Pharmaceuticals.
|